Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Slowing Cognitive Decline in Alpha-synucleinopathies by Enhancing Physical Activity

NCT07324330 is registered in ClinicalTrials.gov with University Hospital, Bonn as lead sponsor.

NCT NCT07324330
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07324330 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Slowing Cognitive Decline in Alpha-synucleinopathies by Enhancing Physical Activity
Lead sponsor
University Hospital, Bonn
Phase
Not applicable
Overall status
Recruiting
Start date
December 4, 2025
Completion date
December 1, 2029
Enrollment
130 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

basal ganglia diseases, brain diseases, central nervous system diseases, cerebral disorder, nervous system diseases, neurodegenerative diseases, parkinson disease, parkinsonian disorders, prodromal stage, synucleinopathies